Form 4 for VIR Vir Biotechnology, Inc.
Accepted 2023-03-31 00:00:00 ET · period of report 2023-03-30 · accession 0001209191-23-021853 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023-03-31 | 2023-03-30 | VIR | HANLY ANN M. | CTO | S - Sale | $22.77 | -2,627 | 114.6K | -2% | -$59.8K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-03-30 | S | D | 2,627 | $22.77 | 114,576 | D | — | — |